Prior studies of type 1 diabetics and newly diagnosed type 2 diabetics have suggested long-term reduction in mortality and macrovascular event risk resulting from earlier periods of tight glucose control. In the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial, blood pressure control in patients with type 2 […]
Tag: type 2 diabetes
Modest benefit from aspirin as primary prevention therapy in diabetics
Although several large trials of aspirin for primary prevention have included diabetic subgroups, no trial has been specifically dedicated to looking at the effects of aspirin in this patient group. […]